For patients who received a letter on improperly disclosed information by a claims processing vendor, read more.
Hemophilia A or B Treatment Study
This study will consist of 3 time periods: a screening period of up to 28 days, 1 day of drug administration and 29 days of follow-up.
In order to participate you must meet the following criteria:
- Have moderate to severe hemophilia A or B.
- Are male at least 18 yeras of age.
This is a partial list of elgibility requirements.